NIH investigators and colleagues have discovered that when the immune system first responds to infectious agents such as viruses or bacteria, a natural brake on the response prevents overactivation. Their new study in mBio describes this brake and the way pathogens such as SARS-CoV-2, the virus that causes COVID-19, turn it on. Their finding provides a potential target for an immunotherapy that might be applied to a wide range of infectious diseases.
- New drug combination shows promise as powerful treatment for AML
- Childhood neglect leaves generational imprint
- New approach emerges to better classify, treat brain tumors
- Certain parenting behaviors associated with positive changes in well-being during COVID-19 pandemic
- Do children view punishment as rehabilitative? A new study takes a look